Adel Giaid, PhD
Primary Axis:
Respiratory Health
Secondary Axis:
Cardiovascular Diseases and Critical Care
Email:
Email contact form Research Focus:
Investigative research in the role of endothelial-derived vasoactive substances in the initiation and progression of cardiovascular diseases such atherosclerosis, congestive heart failure and pulmonary hypertension. Work also focuses on identifying new therapeutic approaches to treat and prevent these diseases using chemical and genetic approaches.Cardiology, heart, vasoactive substances, atherosclerosis, pulmonary hypertension
Keywords:
Cardiology, heart, vasoactive substances, atherosclerosis, pulmonary hypertension
Location:
Montreal General Hospital Publications:
Hassan G, Douglas S, Ohlstein E, Giaid A. Expression of Urotensin-II in human coronary athersoclerosis. Accepted in Peptide 2005.
Bousette N, Patel S, Ohlstein EH, Douglas SA, Giaid A. Urotensin-II and atherosclerosis with specific reference to carotid and aortic plaques. Atherosclerosis 2004; 176:117-223.
Douglas SA, Tayara L, Ohlstein HE, Halawa N, Giaid A. Congestive heart failure and expression of myocardial urotensin-II. The Lancet 2002; 359:1990-1997.
